Louisiana State Employees Retirement System lessened its holdings in HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 2.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 24,100 shares of the company’s stock after selling 500 shares during the quarter. Louisiana State Employees Retirement System’s holdings in HealthEquity were worth $1,973,000 at the end of the most recent reporting period.
Several other institutional investors also recently modified their holdings of the business. Truist Financial Corp increased its holdings in HealthEquity by 7.0% in the second quarter. Truist Financial Corp now owns 2,864 shares of the company’s stock valued at $247,000 after purchasing an additional 188 shares during the last quarter. O Shaughnessy Asset Management LLC boosted its stake in HealthEquity by 3.9% during the 1st quarter. O Shaughnessy Asset Management LLC now owns 5,219 shares of the company’s stock worth $426,000 after acquiring an additional 197 shares during the last quarter. Nisa Investment Advisors LLC grew its holdings in HealthEquity by 7.5% during the second quarter. Nisa Investment Advisors LLC now owns 2,854 shares of the company’s stock valued at $246,000 after purchasing an additional 198 shares during the period. Elk River Wealth Management LLC increased its stake in HealthEquity by 0.3% in the third quarter. Elk River Wealth Management LLC now owns 66,181 shares of the company’s stock valued at $5,417,000 after purchasing an additional 217 shares in the last quarter. Finally, CWM LLC raised its holdings in HealthEquity by 6.9% in the second quarter. CWM LLC now owns 3,958 shares of the company’s stock worth $341,000 after purchasing an additional 255 shares during the period. Institutional investors and hedge funds own 99.55% of the company’s stock.
Insider Activity
In other news, Director Robert W. Selander sold 8,250 shares of the company’s stock in a transaction dated Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total value of $684,585.00. Following the sale, the director now directly owns 54,719 shares of the company’s stock, valued at approximately $4,540,582.62. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, Director Robert W. Selander sold 8,250 shares of the business’s stock in a transaction that occurred on Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total transaction of $684,585.00. Following the transaction, the director now directly owns 54,719 shares of the company’s stock, valued at approximately $4,540,582.62. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Frank Corvino sold 1,247 shares of the firm’s stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total value of $100,084.22. Following the sale, the director now directly owns 4,823 shares of the company’s stock, valued at $387,093.98. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 2.20% of the company’s stock.
HealthEquity Stock Down 0.8 %
HealthEquity (NASDAQ:HQY – Get Free Report) last released its earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share for the quarter, beating the consensus estimate of $0.50 by $0.16. The business had revenue of $299.93 million during the quarter, compared to analysts’ expectations of $284.48 million. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. On average, equities analysts predict that HealthEquity, Inc. will post 2.27 EPS for the current fiscal year.
Analyst Ratings Changes
HQY has been the subject of several research analyst reports. Bank of America decreased their price target on shares of HealthEquity from $105.00 to $100.00 and set a “buy” rating for the company in a report on Wednesday, September 4th. Royal Bank of Canada restated an “outperform” rating and issued a $92.00 price target on shares of HealthEquity in a report on Wednesday, September 4th. Barrington Research reiterated an “outperform” rating and set a $105.00 price objective on shares of HealthEquity in a report on Friday, September 20th. JMP Securities reissued a “market outperform” rating and set a $105.00 target price on shares of HealthEquity in a research note on Wednesday, September 4th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on shares of HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. Twelve analysts have rated the stock with a buy rating, According to MarketBeat, HealthEquity presently has a consensus rating of “Buy” and an average target price of $103.83.
View Our Latest Research Report on HealthEquity
About HealthEquity
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
See Also
- Five stocks we like better than HealthEquity
- What Are the U.K. Market Holidays? How to Invest and Trade
- Is McDonald’s Stock a Smart Buy After Sell-Off and Earnings?
- What Are the FAANG Stocks and Are They Good Investments?
- QuantumScape: Solid State EV Batteries Nearing Commercialization
- Why Invest in High-Yield Dividend Stocks?
- MicroStrategy: Is This Bitcoin-Powered Stock a Buy or a Gamble?
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.